Clover Health Investments CLOV Income Statement (2019-2026)

NASDAQ CLOV
$4.96 +0.08 (+1.64%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Clover Health Investments Quarterly Income Statement

Periods 28 quarters
Latest Sep 2026

Clover Health Investments reported revenue of $759.30M and net income of $6.43M for the quarter ended Sep 2026, up 52.9% year over year. This income statement covers 28 quarters of results from Dec 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
432.04M874.38M846.70M856.82M-1,481.34M321.99M320.14M306.03M312.39M346.92M356.26M330.99M336.96M462.33M477.62M496.65M487.71M749.19M743.17M759.30M
Cost of RevenueCost of Rev
441.93M861.72M858.79M839.80M-1,567.23M274.79M244.26M235.79M249.75M265.16M248.35M249.77M243.04M353.44M377.99M423.47M413.50M589.65M590.17M629.46M
Gross Profit
-9.89M12.66M-12.09M17.02M85.89M47.20M75.88M70.24M62.63M81.76M107.91M81.21M93.92M108.89M99.63M73.18M74.21M159.54M153.00M129.85M
Operating items
Selling, General & AdministrativeSG&A
55.18M57.70M47.04M47.83M51.11M57.64M41.71M41.03M42.71M44.57M44.42M35.20M52.29M50.68M48.48M48.95M66.16M74.63M70.30M66.83M
Restructuring CostsRestructuring
1.81M4.75M1.31M1.95M0.40M0.50M-0.54M
Other Operating ExpensesOther Opex
0.07M342.24M302.56M297.30M330.86M324.66M304.15M305.11M306.13M412.93M439.70M472.07M470.87M647.23M644.87M686.04M
Operating ExpensesOpex
618.83M961.86M949.43M930.91M-1,458.98M401.69M349.02M339.64M375.52M369.63M349.07M339.77M358.41M463.61M488.18M521.03M537.03M721.86M715.17M752.87M
Operating IncomeOp. Inc
-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M28.00M6.44M
Non-operating items
Non Operating Interest Expenses
0.40M0.40M0.39M0.40M0.14M0.01M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
12.39M-1.23M-0.98M-0.97M-4.73M-0.47M-1.20M-0.88M-1.80M
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
22.43M0.09M0.02M0.03M0.02M0.00M
Net income details
EBIT
-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M28.00M6.44M
EBT
-187.19M-87.88M-103.12M-74.50M-22.50M-79.70M-28.89M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M28.00M6.44M
Income After Tax
-187.19M-87.88M-103.12M-74.50M-22.50M-79.70M-28.89M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M28.00M6.44M
Income from Continuing OperationsIncome (Continuing)
-187.19M-87.88M-103.12M-74.50M-22.50M-79.70M-28.89M-33.62M-67.95M-23.17M7.17M-8.79M-21.48M-1.27M-10.58M-24.38M-49.32M26.13M28.00M6.44M
Income from Discontinued OperationsIncome (Discontinued)
7.09M0.08M-7.85M-2.53M4.00M0.24M-0.40M-0.60M
Consolidated Net IncomeConsol Net Inc.
-187.20M-75.49M-104.36M-75.49M-84.23M-72.61M-28.81M-41.47M-70.47M-19.17M7.41M-9.16M-22.09M-1.27M-10.58M-24.38M-49.32M26.13M28.00M6.44M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
-28.50M-19.36M7.71M236.00M-10.33M-24.08M27.12M4.63M
Income towards Parent CompanyParent Net Inc
-187.20M-75.49M-104.36M-75.49M-84.23M-72.61M-28.81M-41.47M-70.47M-19.17M7.41M-9.16M-22.09M-1.27M-10.58M-24.38M-49.32M27.33M28.00M6.44M
Net Income towards Common StockholdersNet Income
-187.20M-75.49M-104.36M-75.49M-84.23M-72.61M-28.81M-41.47M-70.47M-19.17M7.41M-9.16M-22.09M-1.27M-10.58M-24.38M-49.32M27.33M28.00M6.44M
Additional items
EPS (Basic)
-0.45-0.16-0.22-0.16-0.18-0.15-0.06-0.09-0.15-0.040.02-0.02-0.050.00-0.02-0.05-0.100.050.050.01
EPS (Diluted)
-0.45-0.16-0.22-0.16-0.18-0.15-0.06-0.09-0.15-0.030.01-0.02-0.050.00-0.02-0.05-0.100.050.050.01
Shares Outstanding
412.92M473.03M476.06M477.69M476.24M478.81M479.16M480.77M482.18M486.37M487.48M490.18M490.02M497.06M509.04M512.74M511.97M522.18M524.19M531.60M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
412.92M473.03M476.06M477.69M476.24M478.81M479.16M480.77M482.18M567.45M495.18M490.18M490.02M497.06M509.04M512.74M511.97M532.50M545.45M557.48M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
470.85M473.30M477.40M477.92M478.39M482.63M483.64M487.24M489.05M495.80M496.14M500.29M503.53M506.54M510.76M516.68M519.04M525.27M531.16M533.41M
EBITDA
-185.93M-86.66M-102.12M-73.47M-25.89M-82.95M-27.88M-33.06M-64.05M-23.37M7.52M-8.45M-21.83M-0.81M-10.17M-23.97M-49.82M27.85M28.57M7.05M
Interest ExpensesInt Expense
0.40M0.40M0.39M0.40M0.14M0.01M

Clover Health Investments Income Statement API

Pull Clover Health Investments's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLOV&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY